Bill > S667

This bill prohibits cost-sharing (out-of-pocket expenses for the patient) for opioid antagonists, such as naloxone, which are used to reverse opioid overdoses. The bill requires various insurance plans, including those offered by the state's Group Insurance Commission, Medicaid, and private insurers, to provide coverage for opioid antagonists with no patient cost-sharing, with an exception if the plan would lose its tax-exempt status as a result. Additionally, the bill specifies that a prescription is not required for coverage of opioid antagonists under the statewide standing order.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/193/S667